快而精医药 QGEN 深 沪
已收盘 02-06 16:00:00 美东时间
50.95
-0.280
-0.55%
华盛通- 最 高51.64
- 今 开51.25
- 成交量 258.63万股
- 最 低 50.805
- 昨 收 51.23
- 总市值 105.37亿
- 52周最高 57.815
- 市盈率 静 24.94
- 换手率 1.25%
- 52周最低 36.9369
- 委 比 -22.70%
- 总股本 2.07亿
- 历史最高 60.3887
- 量 比 0.86
- 振 幅 1.63%
- 历史最低 7.7822
- 每 手 1
- 风险率 4.07%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多Stifel Maintains Hold on Qiagen, Raises Price Target to $50
Stifel analyst Daniel Arias maintains Qiagen (NYSE:QGEN) with a Hold and raises the price target from $45 to $50.
今天 01:10
Qiagen FY2026 expected to be more than $2.50 vs $2.66 Est; FY2026 Revenue expected to be more than $2.194B vs $2.214B Est
Qiagen (NYSE:QGEN) FY2026 expected to be more than $2.50 vs $2.66 Est. FY2026 Revenue expected to be more than $2.194B vs $2.214B Est
02-05 06:06
Qiagen Q1 expected to be more than $0.54 vs $0.60 Est; Q1 Revenue expected to be more than $487.830M vs $510.941M Est
Qiagen (NYSE:QGEN) Q1 expected to be more than $0.54 vs $0.60 Est. Q1 Revenue expected to be more than $487.830M vs $510.941M Est
02-05 06:06
Qiagen Q4 Earnings Assessment
Qiagen (NYSE:QGEN) released its Q4 earnings on Wednesday, February 4, 2026 at 0...
02-05 05:22
Qiagen Q4 Adj. EPS $0.62 Misses $0.63 Estimate, Sales $540.000M Beat $531.023M Estimate
Qiagen (NYSE:QGEN) reported quarterly earnings of $0.62 per share which missed the analyst consensus estimate of $0.63 by 1.12 percent. This is a 3.33 percent increase over earnings of $0.60 per share from the same
02-05 05:21
美股大行评级 | 潜在涨幅258.31%！Tempest Therapeutics获HC Wainwright上调评级至"买入"，目标价11美元
今日重点评级关注：HC Wainwright & Co.：上调Tempest Therapeutics评级至"买入"，目标价11美元；Guggenheim：维持Sportradar Gr"买入"评级，目标价从34美元升至35美元
01-23 19:46
Deutsche Bank Downgrades Qiagen to Hold, Raises Price Target to $54
Deutsche Bank analyst Jan Koch downgrades Qiagen (NYSE:QGEN) from Buy to Hold and raises the price target from $52 to $54.
01-22 18:12
Qiagen Explores Possible Sale After New Buyer Talks: Report
Qiagen is reviewing strategic options, including a potential sale, after renewed takeover interest from several buyers.
01-21 21:11
'Qiagen Is Said to Consider Strategic Options Amid Fresh Interest' - Bloomberg
https://www.bloomberg.com/news/articles/2026-01-20/qiagen-is-said-to-consider-strategic-options-amid-fresh-interest
01-21 00:46
